Neonatal Fc Receptor (FcRn) Trafficking of Immune Complexes to the Lysosome as a Driver of Glomerulonephritis
新生儿 Fc 受体 (FcRn) 将免疫复合物运输到溶酶体作为肾小球肾炎的驱动因素
基本信息
- 批准号:10535435
- 负责人:
- 金额:$ 40.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AftercareAlbuminsAnimal ModelAntigen-Antibody ComplexApoptosisApoptoticBiochemicalBiological Response ModifiersCD8B1 geneCathepsinsCathepsins BCell DeathCell Membrane PermeabilityCellsCessation of lifeCytosolDegradation PathwayDendritic CellsDepositionDiseaseDisease ProgressionDisease modelEnd stage renal failureEndothelial CellsEnzymesExtravasationFOXP3 geneFc ReceptorFunctional disorderGlomerulonephritisGoalsHealthHistologicHistologyHumanImaging TechniquesImmuneImmune TargetingImmunoglobulin GImmunological ModelsInduction of ApoptosisKidneyKidney DiseasesKidney FailureKnock-outKnockout MiceLocationLupus NephritisLysosomesMacrophageMediatingMediatorMembranous GlomerulonephritisMethodsMitochondriaModelingMorbidity - disease rateMusNephritisOuter Mitochondrial MembranePathway interactionsPatientsPermeabilityPlayProteinuriaProteolytic ProcessingResearchRoleSerumSeverity of illnessSignal TransductionSortingStructureT-LymphocyteTestingUp-RegulationWorkcell typecytochrome cglomerular filtrationglomerulosclerosishuman modelimprovedin vivoin vivo Modelinsightinterestmitochondrial membranemonomermortalitymouse modelneonatal Fc receptornephrotoxicityneutrophilnovelpodocytepreservationpreventresponsetargeted treatmenttraffickingtranscriptome sequencing
项目摘要
Abstract/Project Summary
Immune mediated kidney diseases cause substantial morbidity and often lead to progressive renal failure.
Immune complexes (ICs) have been found in podocytes in a variety of immune mediated kidney diseases but it
is not known how podocytes handle immune complexes and whether trafficking of immune complexes in
podocytes exacerbates glomerulonephritis. The neonatal Fc receptor (FcRn) correctly sorts and traffics ICs in a
variety of cells including podocytes. FcRn is also required to traffic immune complexes to the lysosome in
dendritic cells for proteolytic processing and presentation on MHC II. In preliminary studies, we have found that
podocyte specific knockout of FcRn protects in two models of immune mediated nephritis but that this protection
is not conferred by an immune mediated mechanism. While there is no difference in any of the immune
parameters examined, we have found that there is significantly less apoptotic cell death and upregulation of
apoptotic pathways in FcRn knockout (KO) podocytes treated with immune complexes and significantly
decreased apoptosis in the glomeruli of podocyte specific FcRn KO mice after induction of nephrotoxic serum
nephritis (NTS). In addition, we have found significantly less lysosomal activation and less upregulation of
lysosomal enzymes in FcRn KO podocytes treated with immune complexes. Since FcRn is required to traffic
immune complexes to the lysosome, we hypothesize that in immune mediated nephritis, FcRn directed trafficking
of ICs to the lysosome results in lysosomal dysfunction, upregulation of the intrinsic apoptotic pathway and
podocyte death. To test this hypothesis we will directly examine lysosomal structure and function in WT and
FcRn KO podocytes after an immune challenge using both advanced imaging techniques and biochemical
methods. We will also examine whether FcRn mediated trafficking of immune complexes to the lysosome results
in increased lysosomal permeability and leakage of lysosomal cathepsins into the cytosol causing degradation
of mitochondrial membrane integrity, leakage of cytochrome c and upregulation of intrinsic apoptotic pathways.
We will test whether podocyte specific knockout of FcRn results in decreased lysosomal activation and improved
lysosomal function in podocytes in vivo after induction of immune mediated kidney disease (NTS) and whether
this in turn results in less apoptotic cell death, an increased number of viable podocytes and less severe disease
as assessed by functional and histologic parameters. Since upregulation of lysosomal cathepsins correlates with
more severe lupus nephritis in patients, we will also examine whether podocyte specific knockout of FcRn
ameliorates lupus nephritis in a spontaneous mouse model of this disease. Taken together, the proposed work
will provide novel insights into FcRn mediated trafficking of immune complexes in podocytes and may allow for
the creation of targeted therapies to slow or prevent progression of immune mediated glomerulonephritis.
摘要/项目摘要
免疫介导的肾脏疾病会导致大量发病率,并经常导致肾衰竭。
在多种免疫介导的肾脏疾病的足细胞中发现了免疫复合物(IC),但
尚不知道足细胞如何处理免疫复合物以及免疫复合物的运输是否在
足细胞加剧肾小球肾炎。新生儿FC受体(FCRN)正确地分类了AC
包括足细胞在内的各种细胞。还需要FCRN将免疫复合物传输到溶酶体中
在MHC II上进行蛋白水解加工和表现的树突状细胞。在初步研究中,我们发现
FCRN的足细胞特异性敲除在两种免疫介导的肾炎模型中保护
不受免疫介导的机制赋予。虽然任何免疫都没有差异
检查了参数,我们发现凋亡细胞死亡和上调明显较少
用免疫复合物处理的FCRN敲除(KO)足细胞中的凋亡途径
诱导肾毒性血清后足细胞特异性FCRN KO小鼠的肾小球凋亡降低
肾炎(NTS)。此外,我们发现溶酶体激活明显较少,上调的上调
用免疫复合物处理的FCRN KO足细胞中的溶酶体酶。由于需要fcrn流量
免疫复合物对溶酶体,我们假设在免疫介导的肾炎中,FCRN指导运输
溶酶体的ICS导致溶酶体功能障碍,内在凋亡途径的上调和
足细胞死亡。为了检验这一假设,我们将直接检查WT中的溶酶体结构和功能
通过先进的成像技术和生化,免疫挑战后的FCRN KO足细胞
方法。我们还将检查FCRN是否介导了免疫复合物对溶酶体结果的运输
在增加的溶酶体渗透性和溶酶体组织蛋白酶渗漏到细胞质中,导致降解
线粒体膜完整性,细胞色素C的泄漏以及内在凋亡途径的上调。
我们将测试FCRN的Podocyte特异性敲除是否导致溶酶体激活降低并改善
免疫介导的肾脏疾病(NTS)诱导后体内足细胞中的溶酶体功能
这反过
如功能和组织学参数所评估。由于溶酶体组织蛋白的上调与
患者中更严重的狼疮肾炎,我们还将检查Podocyte特异性敲除FCRN的特异性敲除
在这种疾病的自发小鼠模型中改善狼疮肾炎。两者一起,拟议的工作
将提供有关FCRN介导的型免疫复合物的介导的洞察力的新见解,并可能允许
产生靶向疗法以减慢或防止免疫介导的肾小球肾炎的进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JUDITH T., BLAINE其他文献
JUDITH T., BLAINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JUDITH T., BLAINE', 18)}}的其他基金
A Novel Driver of Hyperphosphatemia and Vascular Calcification in CKD
CKD 中高磷血症和血管钙化的新驱动因素
- 批准号:
10546434 - 财政年份:2020
- 资助金额:
$ 40.55万 - 项目类别:
A Novel Driver of Hyperphosphatemia and Vascular Calcification in CKD
CKD 中高磷血症和血管钙化的新驱动因素
- 批准号:
10132495 - 财政年份:2020
- 资助金额:
$ 40.55万 - 项目类别:
A Novel Driver of Hyperphosphatemia and Vascular Calcification in CKD
CKD 中高磷血症和血管钙化的新驱动因素
- 批准号:
10308103 - 财政年份:2020
- 资助金额:
$ 40.55万 - 项目类别:
The Dual Role of the Neonatal Fc Receptor (FcRn) in Podocytes
新生儿 Fc 受体 (FcRn) 在足细胞中的双重作用
- 批准号:
9338229 - 财政年份:2015
- 资助金额:
$ 40.55万 - 项目类别:
Neonatal Fc Receptor (FcRn) Trafficking of Immune Complexes to the Lysosome as a Driver of Glomerulonephritis
新生儿 Fc 受体 (FcRn) 将免疫复合物运输到溶酶体作为肾小球肾炎的驱动因素
- 批准号:
10319184 - 财政年份:2015
- 资助金额:
$ 40.55万 - 项目类别:
The Dual Role of the Neonatal Fc Receptor (FcRn) in Podocytes
新生儿 Fc 受体 (FcRn) 在足细胞中的双重作用
- 批准号:
9117538 - 财政年份:2015
- 资助金额:
$ 40.55万 - 项目类别:
Molecular Mechanisms of Albumin Trafficking in Podocytes
足细胞白蛋白运输的分子机制
- 批准号:
8690842 - 财政年份:2013
- 资助金额:
$ 40.55万 - 项目类别:
Molecular Mechanisms of Albumin Trafficking in Podocytes
足细胞白蛋白运输的分子机制
- 批准号:
8566186 - 财政年份:2013
- 资助金额:
$ 40.55万 - 项目类别:
Molecular Mechanisms of PTH-Mediated Trafficking in Renal Tubular Cells
PTH 介导的肾小管细胞贩运的分子机制
- 批准号:
8535726 - 财政年份:2009
- 资助金额:
$ 40.55万 - 项目类别:
Molecular Mechanisms of PTH-Mediated Trafficking in Renal Tubular Cells
PTH 介导的肾小管细胞贩运的分子机制
- 批准号:
7589936 - 财政年份:2009
- 资助金额:
$ 40.55万 - 项目类别:
相似国自然基金
用于胰腺癌光免疫协同治疗的单分子白蛋白纳米粒及其增敏机制研究
- 批准号:32330060
- 批准年份:2023
- 资助金额:212 万元
- 项目类别:重点项目
巯基介导的花色苷/豌豆白蛋白递送体系与肠道粘蛋白MUC2的粘附作用机制研究
- 批准号:32372360
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
α-乳白蛋白姜黄素纳米复合物通过PepT1-溶酶体提高生物利用度对镉致动脉粥样硬化的干预作用机制研究
- 批准号:82373600
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
小白蛋白调控巨噬细胞极化改善泌乳素瘤耐药的机制研究
- 批准号:82373131
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
适配体修饰的白蛋白他汀纳米粒调控HER2胞内命运改善HER2阳性胃癌疗效的研究
- 批准号:82304400
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
TSPO-PET and MRI Imaging as Novel Imaging Tools for Autoimmune Epilepsy
TSPO-PET 和 MRI 成像作为自身免疫性癫痫的新型成像工具
- 批准号:
10618871 - 财政年份:2022
- 资助金额:
$ 40.55万 - 项目类别:
TSPO-PET and MRI imaging as novel imaging tools for autoimmune epilepsy
TSPO-PET 和 MRI 成像作为自身免疫性癫痫的新型成像工具
- 批准号:
10412595 - 财政年份:2022
- 资助金额:
$ 40.55万 - 项目类别:
Long acting and peripherally restricted kappa-opioid receptor agonists for acute migraine treatment
用于治疗急性偏头痛的长效外周限制型κ阿片受体激动剂
- 批准号:
10324497 - 财政年份:2021
- 资助金额:
$ 40.55万 - 项目类别:
Albumin Binding siRNAs for Systemic Treatment of Multi-Joint Osteoarthritis
白蛋白结合 siRNA 用于多关节骨关节炎的全身治疗
- 批准号:
10358582 - 财政年份:2021
- 资助金额:
$ 40.55万 - 项目类别:
Long acting and peripherally restricted kappa-opioid receptor agonists for acute migraine treatment
用于治疗急性偏头痛的长效外周限制型κ阿片受体激动剂
- 批准号:
10487454 - 财政年份:2021
- 资助金额:
$ 40.55万 - 项目类别: